Groff North America

Groff North America's Cannabis Products

Groff North America offers a diverse array of cannabis products, catering to various needs and preferences. Their product lineup includes Cannabis Flower, THC & CBD Extracts, Terpenes, and Isolates. These offerings are meticulously crafted to ensure quality and efficacy, making them suitable for both recreational and medical use. The company’s commitment to high-quality cannabis products is evident in their rigorous processes and high standards. This comprehensive product portfolio allows Groff North America to remain competitive and adaptable in the rapidly evolving cannabis market.

Groff North America's DEA Authorizations and Schedule I Registrations

In 2021, Groff North America achieved a significant milestone by being awarded a suite of Schedule I registrations from the DEA. These registrations encompass Bulk Manufacturing, Non-Bulk Manufacturing (Patient Dose), Importer, Exporter, Researcher, and Analytical Lab. This authorization enables Groff North America to legally grow 100% federally-legal cannabis, positioning them as one of only three commercially-focused cannabis companies with such comprehensive DEA registrations. This status not only underscores their compliance with federal regulations but also enhances their credibility and operational capabilities in the cannabis sector.

Groff North America's Custom Formulation Services

Groff North America excels in custom formulation services for THC, CBD, Terpenes, and other Cannabinoid Isolates. These services are designed to meet the specific needs of various clients, spanning sectors such as pharmaceuticals, wellness, and consumer goods. By leveraging their expertise in cannabinoid science and extraction technologies, Groff North America can create tailored solutions that optimize the therapeutic and sensory properties of cannabis products. Their ability to produce custom blends, including specific terpene profiles for applications like vaporizer cartridges, beverages, and candles, sets them apart in the industry.

Groff North America's Pharmaceutical and API Manufacturing

Groff North America is deeply involved in Active Pharmaceutical Ingredient (API) Manufacturing and Pharmaceutical Development. This specialization is crucial for producing high-quality, consistent, and pure cannabis-derived compounds for medical use. Their pharmaceutical-grade full spectrum distillate and 99%+ pure cannabinoid isolates are a testament to their commitment to quality and efficacy. These products are essential for developing cannabis-based therapies and medications, demonstrating Groff North America's pivotal role in advancing cannabis science and medicine.

Groff North America's Global Operations and Collaborations

Based in York, Pennsylvania, Groff North America operates on a global scale, importing and exporting cannabis worldwide. Their comprehensive DEA registrations facilitate these international operations, allowing them to serve a broad market. Additionally, Groff North America partners with a Pennsylvania college to offer a first-of-its-kind cannabinoid major, reflecting their dedication to education and research in the field of cannabis. These initiatives highlight Groff North America's leadership and innovative approach in the cannabis industry, fostering growth and development through strategic collaborations and global reach.